目次

1. Report Overview
1.1 Introduction to Drug Delivery Technologies Market
1.2 Why You Should Read This Report
1.3 What This Report Delivers
1.4 Key Questions Answered By This Analytical Report Include:
1.5 Who is This Report For?
1.6 Methodology
1.6.1 Primary Research
1.6.2 Secondary Research
1.6.3 Market Evaluation & Forecast Methodology
1.7 Frequently Asked Questions (FAQs)
1.8 Associated Visiongain Reports
1.9 About Visiongain

2 Executive Summary

3 Market Dynamics
3.1 Drivers for Drug Delivery Technologies Market
3.1.1 Increasing Demand for Pharmaceuticals
3.1.2 Adoption of Advanced Drug Delivery System is projected to boost the Market Growth
3.1.3 Increasing Geriatric Population around the World is Boosting the Demand for Drug Delivery Technologies
3.1.4 Investing In Modern Drug Delivery Technology by Players To Maximise the Revenue Share in the Market
3.2 Restraints for Drug Delivery Technologies Market
3.2.1 Stringent Regulations Associated with Product Launch Hinders the Market Growth
3.2.2 Risk of Injuries Due To Needle Stick Delivery System & Poor Efficiency
3.3 Opportunities for Drug Delivery Technologies Market
3.3.1 Adoption of Self-Administrative Drug Delivery Methods is Gaining Popularity
3.3.2 Rising Awareness and Adoption for Quality Medical Treatment Due To Rising Disposable Income
3.3.3 Rising Public-Private Funding For Development, Expansion And Adoption Of Novel Drug Delivery Technologies
3.4 Trends for Drug Delivery Technologies Market
3.4.1 Outbreak of COVID-19 Pandemic
3.4.2 Reducing the Environmental Impact with Technology Advancements in Drug Delivery Technology
3.4.3 Developing Connected Drug Delivery Systems With Remote Access
3.5 SWOT Analysis for Drug Delivery Technologies Market
3.5.1 Strengths: Drug Delivery Technologies Market
3.5.1.1 Rising Need for Effective Drugs’ Absorption and Convenient Self-Administration Emphasizes the Importance of the R&D Investment
3.5.2 Weaknesses: Drug Delivery Technologies Market
3.5.2.1 Financial Loss Due To Innovative Drug Delivery Technology Failure Has Been a Perennial Problem
3.5.3 Opportunities: Drug Delivery Technologies Market
3.5.3.1 Increase in Number of Collaborations between Biopharmaceutical Companies
3.5.4 Threats: Drug Delivery Technologies Market
3.5.4.1 Adverse-Drug Reactions and Drug Delivery-Based Injuries could Limit the Adoption of Drugs
3.6 Porter’s Five Forces Analysis: Drug Delivery Technologies Market
3.6.1 Bargaining Power of Supplier: High
3.6.2 Bargaining Power of Buyer: Moderate
3.6.3 Competitive Rivalry: High
3.6.4 Threat of New Entrants: Moderate
3.6.5 Threat of Substitutes: Low
3.7 PEST Analysis: Drug Delivery Technologies Market
3.7.1 Political Factors Impacting Drug Delivery Technologies Market
3.7.2 Economic Factors Impacting Drug Delivery Technologies Market
3.7.3 Social Factors Impacting Drug Delivery Technologies Market
3.7.4 Technological Factors Impacting Drug Delivery Technologies Market

4 COVID-19 Impact: Global Drug Delivery Technologies Market
4.1 Global Drug Delivery Technologies Market Forecast, 2021-2031
4.2 COVID-19 Impact Overview
4.3 "V" shaped Recovery - Rapid Decline - Sharp Borrow -Rapid Recovery
4.4 "U" Shaped Recovery -Rapid Decline Early Then Slow - Gradual at the Bottom - Slow Recovery at First - Faster Recovery Later On
4.5 "W" Shaped Recovery -Rapid Decline - Rapid Recovery- Return of Virus - Another Sharp Decline -Recovery
4.6 "L" Shaped Recovery - Rapid Decline - Then Slow Growth

5 Global Drug Delivery Technologies Market Size Forecast 2021-2031 by Technology
5.1 Oral Drug Delivery Therapy Segment: Revenue Forecast 2021-2031
5.1.1 Oral Drug Delivery Therapy is the Largest Revenue Grossing Segment
5.1.2 Recovery Forecasts (V, U, W, L)
5.2 Injectable Drug Delivery Segment: Revenue Forecast 2021-2031
5.2.1 Rising Prevalence of Chronic Diseases is Driving Injectables Segment
5.2.2 Recovery Forecasts (V, U, W, L)
5.3 Topical Drug Delivery Segment: Revenue Forecast 2021-2031
5.3.1 Rising Incidence Of Skin & Tissue Related Illness Bosting the Adoption Of Topical Drugs
5.3.2 Recovery Forecasts (V, U, W, L)
5.4 Pulmonary Drug Delivery Segment: Revenue Forecast 2021-2031
5.4.1 Market For Pulmonary Drug Delivery Is Increasing Due To Innovations In Excipients, Propellants, And Device Technologies
5.4.2 Recovery Forecasts (V, U, W, L)
5.5 Implantable Drug Delivery Segment: Revenue Forecast 2021-2031
5.5.1 Merger Of Implantable Devices With Novel Drug Therapies, Has Considerably Increased
5.5.2 Recovery Forecasts (V, U, W, L)
5.6 Ocular Drug Delivery Segment: Revenue Forecast 2021-2031
5.6.1 Rising Investments In Research & Development
5.6.2 Recovery Forecasts (V, U, W, L)
5.7 Other Drug Delivery Technologies Segment: Revenue Forecast 2021-2031
5.7.1 Adoption Nasal Drug Delivery Technologies is expected to boost the Others Segment Growth
5.7.2 Recovery Forecasts (V, U, W, L)

6 Global Drug Delivery Technologies Market Size Forecast 2021-2031 by Indication
6.1 Infectious Diseases Therapy Segment: Revenue Forecast 2021-2031
6.1.1 Infectious Diseases Therapy is the Largest Revenue Grossing Segment
6.1.2 Recovery Forecasts (V, U, W, L)
6.2 Cancer Segment: Revenue Forecast 2021-2031
6.2.1 Adaptation Of Nanotechnology Has Also Impacted Positively On The Cancer Segment Growth
6.2.2 Recovery Forecasts (V, U, W, L)
6.3 Cardiovascular Diseases Segment: Revenue Forecast 2021-2031
6.3.1 Growing Geriatric Population, Technological Advancements, Coupled With Rising Cardiovascular Illness Are Factors Driving The Growth Of This Segment
6.3.2 Recovery Forecasts (V, U, W, L)
6.4 Diabetes Segment: Revenue Forecast 2021-2031
6.4.1 Technical Advances That Promote The Effective Drug Functioning Coupled With Minimal Administration Of Dosage
6.4.2 Recovery Forecasts (V, U, W, L)
6.5 Respiratory Diseases Segment: Revenue Forecast 2021-2031
6.5.1 Increasing Incidences Of Chronic Respiratory Disorders Is Driving The Respiratory Diseases Segment
6.5.2 Recovery Forecasts (V, U, W, L)
6.6 Central Nervous System Disorders Segment: Revenue Forecast 2021-2031
6.6.1 Public-Private Investments Are Factors Driving The Growth Of CNS Disorders Segment
6.6.2 Recovery Forecasts (V, U, W, L)
6.7 Other Indications Segment: Revenue Forecast 2021-2031
6.7.1 Other Indications Market Is Expected To Grow At A Lucrative CAGR During The Forecast Period
6.7.2 Recovery Forecasts (V, U, W, L)

7 Drug Delivery Technologies Market by End-User Forecast, 2021-2031
7.1 Hospitals Segment Market Forecast, 2021-2031
7.1.1 Hospitals Segment Accounted for the Largest Revenue Share
7.1.2 Recovery Scenarios (V, U, W, L)
7.2 Homecare Settings Segment Market Forecast, 2021-2031
7.2.1 Advancement In Portable & Wearable Medical Devices Drives the Homecare Settings Market
7.2.2 Recovery Scenarios (V, U, W, L)
7.3 Other End-User Segment: Revenue Forecast 2021-2031
7.3.1 Increasing Preference for ACS Is Driving The Growth Of This Segment
7.3.2 Recovery Forecasts (V, U, W, L)

8 National Drug Delivery Technologies Market Forecast, 2021-2031
8.1 Global Drug Delivery Technologies Market by Region Forecast 2021-2031
8.1 Recovery Scenarios (V, U, W, L)

9 North America Drug Delivery Technologies Market, 2021-2031
9.1 North America is the Largest Revenue Grossing Region in the Global Market
9.2 North America Drug Delivery Technologies Market by Country, Forecast 2021-2031
9.2.1 Recovery Scenarios (V, U, W, L): North America Drug Delivery Technologies Market Forecast by Country, 2021-2031
9.3 North America Drug Delivery Technologies Market Forecast by Technology
9.3.1 Recovery Scenarios (V, U, W, L): North America Drug Delivery Technologies Market Forecast by Technology, 2021-2031
9.4 North America Drug Delivery Technologies Market Forecast by Indication
9.4.1 Recovery Scenarios (V, U, W, L): North America Drug Delivery Technologies Market Forecast by Indication, 2021-2031
9.5 North America Drug Delivery Technologies Market Forecast by End-User
9.5.1 Recovery Scenarios (V, U, W, L): North America Drug Delivery Technologies Market Forecast by End-User, 2021-2031
9.6 U.S. Drug Delivery Technologies Market Forecast, 2021-2031
9.6.1 Presence of Leading Players is a Major factor driving the U.S. Drug Delivery Technologies Market
9.6.2 Presence of Highly Developed Healthcare Infrastructure
9.6.3 Recovery Scenarios: U.S. Drug Delivery Technologies Market Forecast, 2021-2031
9.7 Canada Drug Delivery Technologies Market Forecast, 2021-2031
9.7.1 Canada Market Anticipated To Witness the Fastest Growth in the North America Region
9.7.2 Growing Research for Drug Delivery Technologies in Canada
9.7.3 Recovery Scenarios: Canada Drug Delivery Technologies Market Forecast, 2021-2031

10 Europe Drug Delivery Technologies Market, 2021-2031
10.1 Second Largest Market in the Global Market
10.2 Europe Drug Delivery Technologies Market by Country, Forecast 2021-2031
10.2.1 Recovery Scenarios (V, U, W, L): Europe Drug Delivery Technologies Market Forecast by Country, 2021-2031
10.3 Europe Drug Delivery Technologies Market Forecast by Technology
10.3.1 Recovery Scenarios (V, U, W, L): Europe Drug Delivery Technologies Market Forecast by Technology, 2021-2031
10.4 Europe Drug Delivery Technologies Market Forecast by Indication
10.4.1 Recovery Scenarios (V, U, W, L): Europe Drug Delivery Technologies Market Forecast by Indication, 2021-2031
10.5 Europe Drug Delivery Technologies Market Forecast by End-User
10.5.1 Recovery Scenarios (V, U, W, L): Europe Drug Delivery Technologies Market Forecast by End-User, 2021-2031
10.6 Germany Drug Delivery Technologies Market Forecast, 2021-2031
10.6.1 Growing Geriatric Population In This Region Is Expected To Boost The Regional Market Growth
10.6.2 Rising Expansion of Pharmaceutical Industry in Germany
10.6.3 Recovery Scenarios: Germany Drug Delivery Technologies Market Forecast, 2021-2031
10.7 UK Drug Delivery Technologies Market Forecast, 2021-2031
10.7.1 Presence of Well-Developed R&D Infrastructure
10.7.2 Rise in Prevalence of Chronic Diseases in the UK
10.7.3 Recovery Scenarios: UK Drug Delivery Technologies Market Forecast, 2021-2031
10.8 France Drug Delivery Technologies Market Forecast, 2021-2031
10.8.1 Growing Demand for Advanced Healthcare Services
10.8.2 Pharmaceutical Companies Looking For Opportunities In The French Market
10.8.3 Recovery Scenarios: France Drug Delivery Technologies Market Forecast, 2021-2031
10.9 Italy Drug Delivery Technologies Market Forecast, 2021-2031
10.9.1 Pharmaceutical Manufacturing Hub
10.9.2 Highly Efficient Healthcare System in Italy is projected to drive the Market Growth
10.9.3 Recovery Scenarios: Italy Drug Delivery Technologies Market Forecast, 2021-2031
10.10 Spain Drug Delivery Technologies Market Forecast, 2021-2031
10.10.1 Demand for Drugs Is Influenced By the Growth of the Pharmaceutical Industry
10.10.2 Spanish Economy Is Growing Strong
10.10.3 Recovery Scenarios: Spain Drug Delivery Technologies Market Forecast, 2021-2031
10.11 Russia Drug Delivery Technologies Market Forecast, 2021-2031
10.11.1 Growing Government Support for the Development of Advanced Cancer Therapies
10.11.2 Unmet Pharmaceutical Needs
10.11.3 Recovery Scenarios: Russia Drug Delivery Technologies Market Forecast, 2021-2031
10.12 Rest of Europe Drug Delivery Technologies Market Forecast, 2021-2031
10.12.1 Increasing Prevalence of Cancer
10.12.2 Recovery Scenarios: Rest of Europe Drug Delivery Technologies Market Forecast, 2021-2031

11 Asia Pacific Drug Delivery Technologies Market, 2021-2031
11.1 Asia Pacific is the Fastest Growing Market
11.2 Asia Pacific Drug Delivery Technologies Market by Country, Forecast 2021-2031
11.2.1 Recovery Scenarios (V, U, W, L): Asia Pacific Drug Delivery Technologies Market Forecast by Country, 2021-2031
11.3 Asia Pacific Drug Delivery Technologies Market Forecast by Technology
11.3.1 Recovery Scenarios (V, U, W, L): Asia Pacific Drug Delivery Technologies Market Forecast by Technology, 2021-2031
11.4 Asia Pacific Drug Delivery Technologies Market Forecast by Indication
11.4.1 Recovery Scenarios (V, U, W, L): Asia Pacific Drug Delivery Technologies Market Forecast by Indication, 2021-2031
11.5 Asia Pacific Drug Delivery Technologies Market Forecast by End-User
11.5.1 Recovery Scenarios (V, U, W, L): Asia Pacific Drug Delivery Technologies Market Forecast by End-User, 2021-2031
11.6 Japan Drug Delivery Technologies Market Forecast, 2021-2031
11.6.1 Japan Accounted For the Largest Market Share in the Asia Pacific Region
11.6.2 Supportive Government Policies is Expected to Drive the Market Growth
11.6.3 Recovery Scenarios: Japan Drug Delivery Technologies Market Forecast, 2021-2031
11.7 China Drug Delivery Technologies Market Forecast, 2021-2031
11.7.1 Rising Prevalence of Cancer and Autoimmune Diseases in China expected to Drive the Market Growth
11.7.2 Increasing Healthcare Spending In China
11.7.3 Recovery Scenarios: China Drug Delivery Technologies Market Forecast, 2021-2031
11.8 India Drug Delivery Technologies Market Forecast, 2021-2031
11.8.1 Developing Healthcare Infrastructure
11.8.2 Increasing Prevalence of Cancer
11.8.3 Recovery Scenarios: India Drug Delivery Technologies Market Forecast, 2021-2031
11.9 Australia Drug Delivery Technologies Market Forecast, 2021-2031
11.9.1 Government Programs to Expand Access to Quality Healthcare
11.9.2 Launch of Cell-based Therapies in Australia is Projected to Boost the Market Growth
11.9.3 Recovery Scenarios: Australia Drug Delivery Technologies Market Forecast, 2021-2031
11.10 South Korea Drug Delivery Technologies Market Forecast, 2021-2031
11.10.1 Growing Healthcare Awareness among People
11.10.2 Rising Cancer Incidence is Expected to Drive theSouth Korea Market
11.10.3 Recovery Scenarios: South Korea Drug Delivery Technologies Market Forecast, 2021-2031
11.11 Rest of Asia Pacific Drug Delivery Technologies Market Forecast, 2021-2031
11.11.1 Rising Disposable Income
11.11.2 Recovery Scenarios: Rest of Asia Pacific Drug Delivery Technologies Market Forecast, 2021-2031

12 Latin America Drug Delivery Technologies Market, 2021-2031
12.1 Latin America Drug Delivery Technologies Market
12.2 Latin America Drug Delivery Technologies Market by Country, Forecast 2021-2031
12.2.1 Recovery Scenarios (V, U, W, L): Latin America Drug Delivery Technologies Market Forecast by Country, 2021-2031
12.3 Latin America Drug Delivery Technologies Market Forecast by Technology
12.3.1 Recovery Scenarios (V, U, W, L): Latin America Drug Delivery Technologies Market Forecast by Technology, 2021-2031
12.4 Latin America Drug Delivery Technologies Market Forecast by Indication
12.4.1 Recovery Scenarios (V, U, W, L): Latin America Drug Delivery Technologies Market Forecast by Indication, 2021-2031
12.5 Latin America Drug Delivery Technologies Market Forecast by End-User
12.5.1 Recovery Scenarios (V, U, W, L): Latin America Drug Delivery Technologies Market Forecast by End-User, 2021-2031
12.6 Brazil Drug Delivery Technologies Market Forecast, 2021-2031
12.6.1 Fastest Growing Economy in Latin America
12.6.2 High Potential Manufacturing Environment
12.6.3 Recovery Scenarios: Brazil Drug Delivery Technologies Market Forecast, 2021-2031
12.7 Mexico Drug Delivery Technologies Market Forecast, 2021-2031
12.7.1 Lower Manufacturing Costs than In the US
12.7.2 Strategic Initiatives Undertaken By Market Players
12.7.3 Recovery Scenarios: Mexico Drug Delivery Technologies Market Forecast, 2021-2031
12.8 Rest of Latin America Drug Delivery Technologies Market Forecast, 2021-2031
12.8.1 Evolving Healthcare Infrastructure in Latin America
12.8.2 Recovery Scenarios: Rest of Latin America Drug Delivery Technologies Market Forecast, 2021-2031

13 MEA Drug Delivery Technologies Market, 2021-2031
13.1 Rising Prevalence of Cancer in MEA Region
13.2 MEA Drug Delivery Technologies Market by Country, Forecast 2021-2031
13.2.1 Recovery Scenarios (V, U, W, L): MEA Drug Delivery Technologies Market Forecast by Country, 2021-2031
13.3 MEA Drug Delivery Technologies Market Forecast by Technology
13.3.1 Recovery Scenarios (V, U, W, L): MEA Drug Delivery Technologies Market Forecast by Technology, 2021-2031
13.4 MEA Drug Delivery Technologies Market Forecast by Indication
13.4.1 Recovery Scenarios (V, U, W, L): MEA Drug Delivery Technologies Market Forecast by Indication, 2021-2031
13.5 MEA Drug Delivery Technologies Market Forecast by End-User
13.5.1 Recovery Scenarios (V, U, W, L): MEA Drug Delivery Technologies Market Forecast by End-User, 2021-2031
13.6 South Africa Drug Delivery Technologies Market Forecast, 2021-2031
13.6.1 Prevalence of Chronic Diseases in South Africa is Increasing Rapidly
13.6.2 Polution From Mining Lead to Severe Medical Conditions
13.6.3 Recovery Scenarios: South Africa Drug Delivery Technologies Market Forecast, 2021-2031
13.7 GCC Drug Delivery Technologies Market Forecast, 2021-2031
13.7.1 Presence of Huge Growth Opportunities
13.7.2 Advances in Immuno-Oncology Have Lead In A Paradigm Change
13.7.3 Recovery Scenarios: GCC Drug Delivery Technologies Market Forecast, 2021-2031
13.8 Rest of MEA Drug Delivery Technologies Market Forecast, 2021-2031
13.8.1 Cancer Is One of the Leading Causes of Death in Rest of MEA
13.8.2 Recovery Scenarios: Rest of MEA Drug Delivery Technologies Market Forecast, 2021-2031

14 Company Profiles: Drug Delivery Technologies Market
14.1 Drug Delivery Technologies Market: Company Share Analysis
14.2 Drug Delivery Technologies Market Recent Developments, 2018-2021
14.3 Novartis AG
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Net Revenue, 2016-2020
14.3.3.2 Business Segments Revenue Shares, 2020
14.3.3.3 Pharmaceuticals Business Unit Revenue Shares, 2020
14.3.3.4 Regional Revenue Shares, 2020
14.3.4 Product Benchmarking
14.3.5 Recent Developments, 2017-2021
14.4 Gilead Sciences, Inc.
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.3.1 Net Revenue, 2016-2020
14.4.3.2 Business Segments Revenue Shares, 2020
14.4.3.3 Regional Revenue Shares, 2020
14.4.4 Product Benchmarking
14.4.5 Recent Developments
14.5 GlaxoSmithKline plc.
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.3.1 Revenue, 2016-2020
14.5.3.2 Pharmaceutical Business Revenue Share, 2020
14.5.3.3 Regional Revenue Shares, 2020
14.5.4 Product Benchmarking
14.5.5 Recent Developments, 2018-2021
14.6 Pfizer Inc.
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.3.1 Net Revenue, 2016-2020
14.6.3.2 Product Revenue Shares, 2020
14.6.3.3 Regional Revenue Shares, 2020
14.6.4 Product Benchmarking
14.6.5 Recent Developments, 2018-2021
14.7 F. Hoffmann-La Roche Ltd.
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.3.1 Net Revenue, 2016-2020
14.7.3.2 Product Revenue Shares, 2020
14.7.3.3 Regional Revenue Shares, 2020
14.7.4 Product Benchmarking
14.7.5 Recent Developments, 2018-2021
14.8 Johnson & Johnson
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.3.1 Revenue, 2016-2020
14.8.3.2 Product Revenue Share, 2020
14.8.3.3 Region Revenue Share, 2020
14.8.4 Product Benchmarking
14.8.5 Recent Developments, 2018-2021
14.9 KINDEVA DRUG DELIVERY
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.3.1 Net Revenue, 2016-2020
14.9.4 Product Benchmarking
14.9.5 Recent Developments, 2018-2021
14.10 Eli Lilly and Company
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Financial Analysis
14.10.3.1 Net Revenue, 2016-2020
14.10.4 Product Benchmarking
14.10.5 Recent Developments, 2018-2021
14.11 AstraZeneca
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.3.1 Net Revenue, 2016-2020
14.11.3.2 Product Revenue Shares, 2020
14.11.3.3 Regional Revenue Shares, 2020
14.11.4 Product Benchmarking
14.11.5 Recent Developments, 2018-2021
14.12 Boehringer Ingelheim International GmbH
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.3.1 Net Revenue, 2016-2020
14.12.3.2 Product Revenue Share, 2020
14.12.3.3 Region Revenue Share, 2020
14.12.4 Product Benchmarking
14.12.5 Recent Developments, 2018-2021
14.13 Amgen Inc.
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Financial Analysis
14.13.3.1 Net Revenue, 2016-2020
14.13.4 Product Benchmarking
14.13.5 Recent Developments, 2018-2021
14.14 Bristol-Myers Squibb Company
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Financial Analysis
14.14.3.1 Net Revenue, 2016-2020
14.14.3.2 Regional Revenue Shares, 2020
14.14.4 Product Benchmarking
14.14.5 Recent Developments, 2018-2021
14.15 Sanofi
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Financial Analysis
14.15.3.1 Net Revenue, 2016-2020
14.15.3.2 Product Revenue Share, 2020
14.15.3.3 Region Revenue Share, 2020
14.15.4 Product Benchmarking
14.15.5 Recent Developments, 2018-2021
14.16 Becton, Dickinson and Company
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Financial Analysis
14.16.3.1 Net Revenue, 2016-2020
14.16.3.2 Product Revenue Share, 2020
14.16.3.3 Region Revenue Share, 2020
14.16.4 Product Benchmarking
14.16.5 Recent Developments, 2018-2021
14.17 Bayer AG
14.17.1 Company Snapshot
14.17.2 Company Overview
14.17.3 Financial Analysis
14.17.3.1 Net Revenue, 2016-2020
14.17.3.2 Product Revenue Share, 2020
14.17.3.3 Region Revenue Share, 2020
14.17.4 Product Benchmarking
14.17.5 Recent Developments, 2018-2021

15 Conclusion and Recommendations
15.1 Concluding Remarks from Visiongain
15.2 Recommendations for Market Players
15.3 Leading Regions and Fastest Growing Region (North America Region Accounted for the Largest Market Share)

List of Tables
Table 1 Global Drug Delivery Technologies Market, 2020 & 2031 (US$bn, CAGR %)
Table 2 Major M&A and Collaborations: Drug Delivery Market
Table 3 Global Drug Delivery Technologies Market Size Forecast: Revenue ($bn), AGR (%), CAGR (%), 2021-2031
Table 4 Global Drug Delivery Technologies Market Size Forecast: Revenue ($bn), AGR (%), CAGR (%), 2021-2031: "V" Shaped Recovery
Table 5 Global Drug Delivery Technologies Market Size Forecast: Revenue ($bn), AGR (%), CAGR (%), 2021-2031: "U" Shaped Recovery
Table 6 Global Drug Delivery Technologies Market Size Forecast: Revenue ($bn), AGR (%), CAGR (%), 2021-2031: "W" Shaped Recovery
Table 7 Global Drug Delivery Technologies Market Size Forecast: Revenue ($bn), AGR (%), CAGR (%), 2021-2031: "L" Shaped Recovery
Table 8 Global Drug Delivery Technologies Market Forecast by Technology, 2021-2031 (US$billion, AGR %, CAGR %)
Table 9 Global Oral Drug Delivery Therapy Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 10 “V” Shaped Recovery: Global Oral Drug Delivery Therapy Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 11 “U” Shaped Recovery: Global Oral Drug Delivery Therapy Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 12 “W” Shaped Recovery: Global Oral Drug Delivery Therapy Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 13 “L” Shaped Recovery: Global Oral Drug Delivery Therapy Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 14 Global Injectable Drug Delivery Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 15 “V” Shaped Recovery: Global Injectable Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 16 “U” Shaped Recovery: Global Injectable Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 17 “W” Shaped Recovery: Global Injectable Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 18 “L” Shaped Recovery: Global Injectable Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 19 Global Topical Drug Delivery Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 20 “V” Shaped Recovery: Global Topical Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 21 “U” Shaped Recovery: Global Topical Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 22 “W” Shaped Recovery: Global Topical Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 23 “L” Shaped Recovery: Global Topical Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 24 Global Pulmonary Drug Delivery Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 25 “V” Shaped Recovery: Global Pulmonary Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 26 “U” Shaped Recovery: Global Pulmonary Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 27 “W” Shaped Recovery: Global Pulmonary Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 28 “L” Shaped Recovery: Global Pulmonary Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 29 Global Implantable Drug Delivery Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 30 “V” Shaped Recovery: Global Implantable Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 31 “U” Shaped Recovery: Global Implantable Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 32 “W” Shaped Recovery: Global Implantable Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 33 “L” Shaped Recovery: Global Implantable Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 34 Global Ocular Drug Delivery Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 35 “V” Shaped Recovery: Global Ocular Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 36 “U” Shaped Recovery: Global Ocular Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 37 “W” Shaped Recovery: Global Ocular Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 38 “L” Shaped Recovery: Global Ocular Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 39 Global Others Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 40 “V” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 41 “U” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 42 “W” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 43 “L” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 44 Global Drug Delivery Technologies Market Size Forecast by Indication, 2021-2031 (US$billion, AGR %, CAGR %)
Table 45 Global Infectious Diseases Therapy Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 46 “V” Shaped Recovery: Global Infectious Diseases Therapy Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 47 “U” Shaped Recovery: Global Infectious Diseases Therapy Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 48 “W” Shaped Recovery: Global Infectious Diseases Therapy Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 49 “L” Shaped Recovery: Global Infectious Diseases Therapy Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 50 Global Cancer Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 51 “V” Shaped Recovery: Global Cancer Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 52 “U” Shaped Recovery: Global Cancer Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 53 “W” Shaped Recovery: Global Cancer Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 54 “L” Shaped Recovery: Global Cancer Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 55 Global Cardiovascular Diseases Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 56 “V” Shaped Recovery: Global Cardiovascular Diseases Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 57 “U” Shaped Recovery: Global Cardiovascular Diseases Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 58 “W” Shaped Recovery: Global Cardiovascular Diseases Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 59 “L” Shaped Recovery: Global Cardiovascular Diseases Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 60 Global Diabetes Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 61 “V” Shaped Recovery: Global Diabetes Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 62 “U” Shaped Recovery: Global Diabetes Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 63 “W” Shaped Recovery: Global Diabetes Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 64 “L” Shaped Recovery: Global Diabetes Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 65 Global Respiratory Diseases Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 66 “V” Shaped Recovery: Global Respiratory Diseases Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 67 “U” Shaped Recovery: Global Respiratory Diseases Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 68 “W” Shaped Recovery: Global Respiratory Diseases Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 69 “L” Shaped Recovery: Global Respiratory Diseases Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 70 Global Central Nervous System Disorders Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 71 “V” Shaped Recovery: Global Central Nervous System Disorders Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 72 “U” Shaped Recovery: Global Central Nervous System Disorders Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 73 “W” Shaped Recovery: Global Central Nervous System Disorders Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 74 “L” Shaped Recovery: Global Central Nervous System Disorders Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 75 Global Other Indications Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 76 “V” Shaped Recovery: Global Other Indications Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 77 “U” Shaped Recovery: Global Other Indications Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 78 “W” Shaped Recovery: Global Other Indications Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 79 “L” Shaped Recovery: Global Other Indications Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 80 Global Drug Delivery Technologies Market Forecast by End-User, 2021-2031 (US$bn, AGR%, CAGR%)
Table 81 Global Hospitals Segment Forecast, 2021-2031 (US$bn, AGR%, CAGR%)
Table 82 Global Hospitals Segment Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "V" Shaped Recovery
Table 83 Global Hospitals Segment Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "U" Shaped Recovery
Table 84 Global Hospitals Segment Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "W" Shaped Recovery
Table 85 Global Hospitals Segment Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "L" Shaped Recovery
Table 86 Global Homecare Settings Segment Forecast, 2021-2031 (US$bn, AGR%, CAGR%)
Table 87 Global Homecare Settings Segment Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "V" Shaped Recovery
Table 88 Global Homecare Settings Segment Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "U" Shaped Recovery
Table 89 Global Homecare Settings Segment Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "W" Shaped Recovery
Table 90 Global Homecare Settings Segment Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "L" Shaped Recovery
Table 91 Global Other End-User Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 92 “V” Shaped Recovery: Global Other End-User Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 93 “U” Shaped Recovery: Global Other End-User Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 94 “W” Shaped Recovery: Global Other End-User Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 95 “L” Shaped Recovery: Global Other End-User Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 96 Global Drug Delivery Technologies Market Forecast by Region, 2021-2031 (US$bn, AGR%, CAGR%)
Table 97 Global Drug Delivery Technologies Market Forecast by Region, 2021-2031 (US$bn, AGR%, CAGR%): "V" Shaped Recovery
Table 98 Global Drug Delivery Technologies Market Forecast by Region, 2021-2031 (US$bn, AGR%, CAGR%): "U" Shaped Recovery
Table 99 Global Drug Delivery Technologies Market Forecast by Region, 2021-2031 (US$bn, AGR%, CAGR%): "W" Shaped Recovery
Table 100 Global Drug Delivery Technologies Market Forecast by Region, 2021-2031 (US$bn, AGR%, CAGR%): "L" Shaped Recovery
Table 101 North America Drug Delivery Technologies Market Forecast, 2021-2031 (US$bn, AGR%, CAGR%)
Table 102 North America Drug Delivery Technologies Market Forecast by Country, 2021-2031 (US$bn, AGR%, CAGR%)
Table 103 “V-Shaped Recovery”: North America Drug Delivery Technologies Market Forecast by Country, 2021-2031 (US$bn, AGR%, CAGR%)
Table 104 “U-Shaped Recovery”: North America Drug Delivery Technologies Market Forecast by Country, 2021-2031 (US$bn, AGR%, CAGR%)
Table 105 “W-Shaped Recovery”: North America Drug Delivery Technologies Market Forecast by Country, 2021-2031 (US$bn, AGR%, CAGR%)
Table 106 “L-Shaped Recovery”: North America Drug Delivery Technologies Market Forecast by Country, 2021-2031 (US$bn, AGR%, CAGR%)
Table 107 North America Drug Delivery Technologies Market Forecast by Technology, 2021-2031 (US$billion, AGR %, CAGR %)
Table 108 “V-Shaped Recovery”: North America Drug Delivery Technologies Market Forecast by Technology, 2021-2031 (US$billion, AGR %, CAGR %)
Table 109 “U-Shaped Recovery”: North America Drug Delivery Technologies Market Forecast by Technology, 2021-2031 (US$billion, AGR %, CAGR %)
Table 110 “W-Shaped Recovery”: North America Drug Delivery Technologies Market Forecast by Technology, 2021-2031 (US$billion, AGR %, CAGR %)
Table 111 “L-Shaped Recovery”: North America Drug Delivery Technologies Market Forecast by Technology, 2021-2031 (US$billion, AGR %, CAGR %)
Table 112 North America Drug Delivery Technologies Market Forecast by indiation, 2021-2031 (US$billion, AGR %, CAGR %)
Table 113 “V-Shaped Recovery”: North America Drug Delivery Technologies Market Forecast by indiation, 2021-2031 (US$billion, AGR %, CAGR %)
Table 114 “U-Shaped Recovery”: North America Drug Delivery Technologies Market Forecast by indiation, 2021-2031 (US$billion, AGR %, CAGR %)
Table 115 “W-Shaped Recovery”: North America Drug Delivery Technologies Market Forecast by indiation, 2021-2031 (US$billion, AGR %, CAGR %)
Table 116 “L-Shaped Recovery”: North America Drug Delivery Technologies Market Forecast by indiation, 2021-2031 (US$billion, AGR %, CAGR %)
Table 117 North America Drug Delivery Technologies Market Forecast by End-User, 2021-2031 (US$bn, AGR%, CAGR%)
Table 118 “V-Shaped Recovery”: North America Drug Delivery Technologies Market Forecast by End-User, 2021-2031 (US$bn, AGR%, CAGR%)
Table 119 “U-Shaped Recovery”: North America Drug Delivery Technologies Market Forecast by End-User, 2021-2031 (US$bn, AGR%, CAGR%)
Table 120 “W-Shaped Recovery”: North America Drug Delivery Technologies Market Forecast by End-User, 2021-2031 (US$bn, AGR%, CAGR%)
Table 121 “L-Shaped Recovery”: North America Drug Delivery Technologies Market Forecast by End-User, 2021-2031 (US$bn, AGR%, CAGR%)
Table 122 U.S. Drug Delivery Technologies Market Forecast, 2021-2031 (US$bn, AGR%, CAGR%)
Table 123 U.S. Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "V" Shaped Recovery
Table 124 U.S. Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "U" Shaped Recovery
Table 125 U.S. Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "W" Shaped Recovery
Table 126 U.S. Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "L" Shaped Recovery
Table 127 Canada Drug Delivery Technologies Market Forecast, 2021-2031 (US$bn, AGR%, CAGR%)
Table 128 Canada Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "V" Shaped Recovery
Table 129 Canada Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "U" Shaped Recovery
Table 130 Canada Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "W" Shaped Recovery
Table 131 Canada Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "L" Shaped Recovery
Table 132 Europe Drug Delivery Technologies Market Forecast, 2021-2031 (US$bn, AGR%, CAGR%)
Table 133 Europe Drug Delivery Technologies Market Forecast by Country, 2021-2031 (US$bn, AGR%, CAGR%)
Table 134 “V-Shaped Recovery”: Europe Drug Delivery Technologies Market Forecast by Country, 2021-2031 (US$bn, AGR%, CAGR%)
Table 135 “U-Shaped Recovery”: Europe Drug Delivery Technologies Market Forecast by Country, 2021-2031 (US$bn, AGR%, CAGR%)
Table 136 “W-Shaped Recovery”: Europe Drug Delivery Technologies Market Forecast by Country, 2021-2031 (US$bn, AGR%, CAGR%)
Table 137 “L-Shaped Recovery”: Europe Drug Delivery Technologies Market Forecast by Country, 2021-2031 (US$bn, AGR%, CAGR%)
Table 138 Europe Drug Delivery Technologies Market Forecast by Technology, 2021-2031 (US$billion, AGR %, CAGR %)
Table 139 “V-Shaped Recovery”: Europe Drug Delivery Technologies Market Forecast by Technology, 2021-2031 (US$billion, AGR %, CAGR %)
Table 140 “U-Shaped Recovery”: Europe Drug Delivery Technologies Market Forecast by Technology, 2021-2031 (US$billion, AGR %, CAGR %)
Table 141 “W-Shaped Recovery”: Europe Drug Delivery Technologies Market Forecast by Technology, 2021-2031 (US$billion, AGR %, CAGR %)
Table 142 “L-Shaped Recovery”: Europe Drug Delivery Technologies Market Forecast by Technology, 2021-2031 (US$billion, AGR %, CAGR %)
Table 143 Europe Drug Delivery Technologies Market Forecast by indiation, 2021-2031 (US$billion, AGR %, CAGR %)
Table 144 “V-Shaped Recovery”: Europe Drug Delivery Technologies Market Forecast by indiation, 2021-2031 (US$billion, AGR %, CAGR %)
Table 145 “U-Shaped Recovery”: Europe Drug Delivery Technologies Market Forecast by indiation, 2021-2031 (US$billion, AGR %, CAGR %)
Table 146 “W-Shaped Recovery”: Europe Drug Delivery Technologies Market Forecast by indiation, 2021-2031 (US$billion, AGR %, CAGR %)
Table 147 “L-Shaped Recovery”: Europe Drug Delivery Technologies Market Forecast by indiation, 2021-2031 (US$billion, AGR %, CAGR %)
Table 148 Europe Drug Delivery Technologies Market Forecast by End-User, 2021-2031 (US$bn, AGR%, CAGR%)
Table 149 “V-Shaped Recovery”: Europe Drug Delivery Technologies Market Forecast by End-User, 2021-2031 (US$bn, AGR%, CAGR%)
Table 150 “U-Shaped Recovery”: Europe Drug Delivery Technologies Market Forecast by End-User, 2021-2031 (US$bn, AGR%, CAGR%)
Table 151 “W-Shaped Recovery”: Europe Drug Delivery Technologies Market Forecast by End-User, 2021-2031 (US$bn, AGR%, CAGR%)
Table 152 “L-Shaped Recovery”: Europe Drug Delivery Technologies Market Forecast by End-User, 2021-2031 (US$bn, AGR%, CAGR%)
Table 153 Germany Drug Delivery Technologies Market Forecast, 2021-2031 (US$bn, AGR%, CAGR %)
Table 154 Germany Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "V" Shaped Recovery
Table 155 Germany Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "U" Shaped Recovery
Table 156 Germany Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "W" Shaped Recovery
Table 157 Germany Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "L" Shaped Recovery
Table 158 UK Drug Delivery Technologies Market Forecast, 2021-2031 (US$bn, AGR%, CAGR%)
Table 159 UK Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "V" Shaped Recovery
Table 160 UK Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "U" Shaped Recovery
Table 161 UK Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "W" Shaped Recovery
Table 162 UK Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "L" Shaped Recovery
Table 163 France Drug Delivery Technologies Market Forecast, 2021-2031 (US$bn, AGR%, CAGR%)
Table 164 France Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "V" Shaped Recovery
Table 165 France Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "U" Shaped Recovery
Table 166 France Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "W" Shaped Recovery
Table 167 France Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "L" Shaped Recovery
Table 168 Italy Drug Delivery Technologies Market Forecast, 2021-2031 (US$bn, AGR%, CAGR%)
Table 169 Italy Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "V" Shaped Recovery
Table 170 Italy Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "U" Shaped Recovery
Table 171 Italy Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "W" Shaped Recovery
Table 172 Italy Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "L" Shaped Recovery
Table 173 Spain Drug Delivery Technologies Market Forecast, 2021-2031 (US$bn, AGR%, CAGR%)
Table 174 Spain Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "V" Shaped Recovery
Table 175 Spain Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "U" Shaped Recovery
Table 176 Spain Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "W" Shaped Recovery
Table 177 Spain Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "L" Shaped Recovery
Table 178 Russia Drug Delivery Technologies Market Forecast, 2021-2031 (US$bn, AGR%, CAGR%)
Table 179 Russia Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "V" Shaped Recovery
Table 180 Russia Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "U" Shaped Recovery
Table 181 Russia Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "W" Shaped Recovery
Table 182 Russia Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "L" Shaped Recovery
Table 183 Rest of Europe Drug Delivery Technologies Market Forecast, 2021-2031 (US$bn, AGR%, CAGR%)
Table 184 Rest of Europe Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "V" Shaped Recovery
Table 185 Rest of Europe Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "U" Shaped Recovery
Table 186 Rest of Europe Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "W" Shaped Recovery
Table 187 Rest of Europe Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "L" Shaped Recovery
Table 188 Asia Pacific Drug Delivery Technologies Market Forecast, 2021-2031 (US$bn, AGR%, CAGR%)
Table 189 Asia Pacific Drug Delivery Technologies Market Forecast by Country, 2021-2031 (US$bn, AGR%, CAGR%)
Table 190 “V-Shaped Recovery”: Asia Pacific Drug Delivery Technologies Market Forecast by Country, 2021-2031 (US$bn, AGR%, CAGR%)
Table 191 “U-Shaped Recovery”: Asia Pacific Drug Delivery Technologies Market Forecast by Country, 2021-2031 (US$bn, AGR%, CAGR%)
Table 192 “W-Shaped Recovery”: Asia Pacific Drug Delivery Technologies Market Forecast by Country, 2021-2031 (US$bn, AGR%, CAGR%)
Table 193 “L-Shaped Recovery”: Asia Pacific Drug Delivery Technologies Market Forecast by Country, 2021-2031 (US$bn, AGR%, CAGR%)
Table 194 Asia Pacific Drug Delivery Technologies Market Forecast by Technology, 2021-2031 (US$billion, AGR %, CAGR %)
Table 195 “V-Shaped Recovery”: Asia Pacific Drug Delivery Technologies Market Forecast by Technology, 2021-2031 (US$billion, AGR %, CAGR %)
Table 196 “U-Shaped Recovery”: Asia Pacific Drug Delivery Technologies Market Forecast by Technology, 2021-2031 (US$billion, AGR %, CAGR %)
Table 197 “W-Shaped Recovery”: Asia Pacific Drug Delivery Technologies Market Forecast by Technology, 2021-2031 (US$billion, AGR %, CAGR %)
Table 198 “L-Shaped Recovery”: Asia Pacific Drug Delivery Technologies Market Forecast by Technology, 2021-2031 (US$billion, AGR %, CAGR %)
Table 199 Asia Pacific Drug Delivery Technologies Market Forecast by indiation, 2021-2031 (US$billion, AGR %, CAGR %)
Table 200 “V-Shaped Recovery”: Asia Pacific Drug Delivery Technologies Market Forecast by indiation, 2021-2031 (US$billion, AGR %, CAGR %)
Table 201 “U-Shaped Recovery”: Asia Pacific Drug Delivery Technologies Market Forecast by indiation, 2021-2031 (US$billion, AGR %, CAGR %)
Table 202 “W-Shaped Recovery”: Asia Pacific Drug Delivery Technologies Market Forecast by indiation, 2021-2031 (US$billion, AGR %, CAGR %)
Table 203 “L-Shaped Recovery”: Asia Pacific Drug Delivery Technologies Market Forecast by indiation, 2021-2031 (US$billion, AGR %, CAGR %)
Table 204 Asia Pacific Drug Delivery Technologies Market Forecast by End-User, 2021-2031 (US$bn, AGR%, CAGR%)
Table 205 “V-Shaped Recovery”: Asia Pacific Drug Delivery Technologies Market Forecast by End-User, 2021-2031 (US$bn, AGR%, CAGR%)
Table 206 “U-Shaped Recovery”: Asia Pacific Drug Delivery Technologies Market Forecast by End-User, 2021-2031 (US$bn, AGR%, CAGR%)
Table 207 “W-Shaped Recovery”: Asia Pacific Drug Delivery Technologies Market Forecast by End-User, 2021-2031 (US$bn, AGR%, CAGR%)
Table 208 “L-Shaped Recovery”: Asia Pacific Drug Delivery Technologies Market Forecast by End-User, 2021-2031 (US$bn, AGR%, CAGR%)
Table 209 Japan Drug Delivery Technologies Market Forecast, 2021-2031 (US$bn, AGR%, CAGR%)
Table 210 Japan Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "V" Shaped Recovery
Table 211 Japan Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "U" Shaped Recovery
Table 212 Japan Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "W" Shaped Recovery
Table 213 Japan Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "L" Shaped Recovery
Table 214 China Drug Delivery Technologies Market Forecast, 2021-2031 (US$bn, AGR%, CAGR%)
Table 215 China Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "V" Shaped Recovery
Table 216 China Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "U" Shaped Recovery
Table 217 China Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "W" Shaped Recovery
Table 218 China Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "L" Shaped Recovery
Table 219 .India Drug Delivery Technologies Market Forecast, 2021-2031 (US$bn, AGR%, CAGR%)
Table 220 India Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "V" Shaped Recovery
Table 221 India Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "U" Shaped Recovery
Table 222 India Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "W" Shaped Recovery
Table 223 India Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "L" Shaped Recovery
Table 224 Australia Drug Delivery Technologies Market Forecast, 2021-2031 (US$bn, AGR%, CAGR%)
Table 225 Australia Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "V" Shaped Recovery
Table 226 Australia Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "U" Shaped Recovery
Table 227 Australia Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "W" Shaped Recovery
Table 228 Australia Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "L" Shaped Recovery
Table 229 South Korea Drug Delivery Technologies Market Forecast, 2021-2031 (US$bn, AGR%, CAGR%)
Table 230 South Korea Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "V" Shaped Recovery
Table 231 South Korea Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "U" Shaped Recovery
Table 232 South Korea Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "W" Shaped Recovery
Table 233 South Korea Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "L" Shaped Recovery
Table 234 Rest of Asia Pacific Drug Delivery Technologies Market Forecast, 2021-2031 (US$bn, AGR%, CAGR%)
Table 235 Rest of Asia Pacific Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "V" Shaped Recovery
Table 236 Rest of Asia Pacific Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "U" Shaped Recovery
Table 237 Rest of Asia Pacific Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "W" Shaped Recovery
Table 238 Rest of Asia Pacific Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "L" Shaped Recovery
Table 239 Latin America Drug Delivery Technologies Market Forecast, 2021-2031 (US$bn, AGR%, CAGR%)
Table 240 Latin America Drug Delivery Technologies Market Forecast by Country, 2021-2031 (US$bn, AGR%, CAGR%)
Table 241 “V-Shaped Recovery”: Latin America Drug Delivery Technologies Market Forecast by Country, 2021-2031 (US$bn, AGR%, CAGR%)
Table 242 “U-Shaped Recovery”: Latin America Drug Delivery Technologies Market Forecast by Country, 2021-2031 (US$bn, AGR%, CAGR%)
Table 243 “W-Shaped Recovery”: Latin America Drug Delivery Technologies Market Forecast by Country, 2021-2031 (US$bn, AGR%, CAGR%)
Table 244 “L-Shaped Recovery”: Latin America Drug Delivery Technologies Market Forecast by Country, 2021-2031 (US$bn, AGR%, CAGR%)
Table 245 Latin America Drug Delivery Technologies Market Forecast by Technology, 2021-2031 (US$billion, AGR %, CAGR %)
Table 246 “V-Shaped Recovery”: Latin America Drug Delivery Technologies Market Forecast by Technology, 2021-2031 (US$billion, AGR %, CAGR %)
Table 247 “U-Shaped Recovery”: Latin America Drug Delivery Technologies Market Forecast by Technology, 2021-2031 (US$billion, AGR %, CAGR %)
Table 248 “W-Shaped Recovery”: Latin America Drug Delivery Technologies Market Forecast by Technology, 2021-2031 (US$billion, AGR %, CAGR %)
Table 249 “L-Shaped Recovery”: Latin America Drug Delivery Technologies Market Forecast by Technology, 2021-2031 (US$billion, AGR %, CAGR %)
Table 250 Latin America Drug Delivery Technologies Market Forecast by indiation, 2021-2031 (US$billion, AGR %, CAGR %)
Table 251 “V-Shaped Recovery”: Latin America Drug Delivery Technologies Market Forecast by indiation, 2021-2031 (US$billion, AGR %, CAGR %)
Table 252 “U-Shaped Recovery”: Latin America Drug Delivery Technologies Market Forecast by indiation, 2021-2031 (US$billion, AGR %, CAGR %)
Table 253 “W-Shaped Recovery”: Latin America Drug Delivery Technologies Market Forecast by indiation, 2021-2031 (US$billion, AGR %, CAGR %)
Table 254 “L-Shaped Recovery”: Latin America Drug Delivery Technologies Market Forecast by indiation, 2021-2031 (US$billion, AGR %, CAGR %)
Table 255 Latin America Drug Delivery Technologies Market Forecast by End-User, 2021-2031 (US$bn, AGR%, CAGR%)
Table 256 “V-Shaped Recovery”: Latin America Drug Delivery Technologies Market Forecast by End-User, 2021-2031 (US$bn, AGR%, CAGR%)
Table 257 “U-Shaped Recovery”: Latin America Drug Delivery Technologies Market Forecast by End-User, 2021-2031 (US$bn, AGR%, CAGR%)
Table 258 “W-Shaped Recovery”: Latin America Drug Delivery Technologies Market Forecast by End-User, 2021-2031 (US$bn, AGR%, CAGR%)
Table 259 “L-Shaped Recovery”: Latin America Drug Delivery Technologies Market Forecast by End-User, 2021-2031 (US$bn, AGR%, CAGR%)
Table 260 Brazil Drug Delivery Technologies Market Forecast, 2021-2031 (US$bn, AGR%, CAGR%)
Table 261 Brazil Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "V" Shaped Recovery
Table 262 Brazil Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "U" Shaped Recovery
Table 263 Brazil Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "W" Shaped Recovery
Table 264 Brazil Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "L" Shaped Recovery
Table 265 Mexico Drug Delivery Technologies Market Forecast, 2021-2031 (US$bn, AGR%, CAGR%)
Table 266 Mexico Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "V" Shaped Recovery
Table 267 Mexico Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "U" Shaped Recovery
Table 268 Mexico Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "W" Shaped Recovery
Table 269 Mexico Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "L" Shaped Recovery
Table 270 Rest of Latin America Drug Delivery Technologies Market Forecast, 2021-2031 (US$bn, AGR%, CAGR%)
Table 271 Rest of Latin America Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "V" Shaped Recovery
Table 272 Rest of Latin America Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "U" Shaped Recovery
Table 273 Rest of Latin America Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "W" Shaped Recovery
Table 274 Rest of Latin America Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "L" Shaped Recovery
Table 275 MEA Drug Delivery Technologies Market Forecast, 2021-2031 (US$bn, AGR%, CAGR%)
Table 276 MEA Drug Delivery Technologies Market Forecast by Country, 2021-2031 (US$bn, AGR%, CAGR%)
Table 277 “V-Shaped Recovery”: MEA Drug Delivery Technologies Market Forecast by Country, 2021-2031 (US$bn, AGR%, CAGR%)
Table 278 “U-Shaped Recovery”: MEA Drug Delivery Technologies Market Forecast by Country, 2021-2031 (US$bn, AGR%, CAGR%)
Table 279 “W-Shaped Recovery”: MEA Drug Delivery Technologies Market Forecast by Country, 2021-2031 (US$bn, AGR%, CAGR%)
Table 280 “L-Shaped Recovery”: MEA Drug Delivery Technologies Market Forecast by Country, 2021-2031 (US$bn, AGR%, CAGR%)
Table 281 MEA Drug Delivery Technologies Market Forecast by Technology, 2021-2031 (US$billion, AGR %, CAGR %)
Table 282 “V-Shaped Recovery”: MEA Drug Delivery Technologies Market Forecast by Technology, 2021-2031 (US$billion, AGR %, CAGR %)
Table 283 “U-Shaped Recovery”: MEA Drug Delivery Technologies Market Forecast by Technology, 2021-2031 (US$billion, AGR %, CAGR %)
Table 284 “W-Shaped Recovery”: MEA Drug Delivery Technologies Market Forecast by Technology, 2021-2031 (US$billion, AGR %, CAGR %)
Table 285 “L-Shaped Recovery”: MEA Drug Delivery Technologies Market Forecast by Technology, 2021-2031 (US$billion, AGR %, CAGR %)
Table 286 MEA Drug Delivery Technologies Market Forecast by indiation, 2021-2031 (US$billion, AGR %, CAGR %)
Table 287 “V-Shaped Recovery”: MEA Drug Delivery Technologies Market Forecast by indiation, 2021-2031 (US$billion, AGR %, CAGR %)
Table 288 “U-Shaped Recovery”: MEA Drug Delivery Technologies Market Forecast by indiation, 2021-2031 (US$billion, AGR %, CAGR %)
Table 289 “W-Shaped Recovery”: MEA Drug Delivery Technologies Market Forecast by indiation, 2021-2031 (US$billion, AGR %, CAGR %)
Table 290 “L-Shaped Recovery”: MEA Drug Delivery Technologies Market Forecast by indiation, 2021-2031 (US$billion, AGR %, CAGR %)
Table 291 MEA Drug Delivery Technologies Market Forecast by End-User, 2021-2031 (US$bn, AGR%, CAGR%)
Table 292 “V-Shaped Recovery”: MEA Drug Delivery Technologies Market Forecast by End-User, 2021-2031 (US$bn, AGR%, CAGR%)
Table 293 “U-Shaped Recovery”: MEA Drug Delivery Technologies Market Forecast by End-User, 2021-2031 (US$bn, AGR%, CAGR%)
Table 294 “W-Shaped Recovery”: MEA Drug Delivery Technologies Market Forecast by End-User, 2021-2031 (US$bn, AGR%, CAGR%)
Table 295 “L-Shaped Recovery”: MEA Drug Delivery Technologies Market Forecast by End-User, 2021-2031 (US$bn, AGR%, CAGR%)
Table 296 South Africa Drug Delivery Technologies Market Forecast, 2021-2031 (US$bn, AGR%, CAGR%)
Table 297 South Africa Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "V" Shaped Recovery
Table 298 South Africa Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "U" Shaped Recovery
Table 299 South Africa Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "W" Shaped Recovery
Table 300 South Africa Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "L" Shaped Recovery
Table 301 GCC Drug Delivery Technologies Market Forecast, 2021-2031 (US$bn, AGR%, CAGR%)
Table 302 GCC Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "V" Shaped Recovery
Table 303 GCC Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "U" Shaped Recovery
Table 304 GCC Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "W" Shaped Recovery
Table 305 GCC Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "L" Shaped Recovery
Table 306 Rest of MEA Drug Delivery Technologies Market Forecast, 2021-2031 (US$bn, AGR%, CAGR%)
Table 307 Rest of MEA Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "V" Shaped Recovery
Table 308 Rest of MEA Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "U" Shaped Recovery
Table 309 Rest of MEA Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "W" Shaped Recovery
Table 310 Rest of MEA Drug Delivery Technologies Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "L" Shaped Recovery
Table 311 Drug Delivery Technology Market Recent Developments, 2018-2021
Table 312 Novartis AG: Key Details, (MD, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 313 Novartis AG: Product Benchmarking
Table 314 Novartis AG : Recent Developments, 2018-2021
Table 315 Gilead Sciences, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 316 Kite Corporate (Gilead Sciences, Inc.): Product Benchmarking
Table 317 GILEAD SCIENCES: Recent Developments, 2019-2021
Table 318 GlaxoSmithKline plc.: Key Details, (MD, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 319 GlaxoSmithKline plc: Product Benchmarking
Table 320 GlaxoSmithKline plc: Recent Developments, 2018-2021
Table 321 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Web